Sign inGet started

Eisenstadt Richard I

Insider CIK 1515806 · TZYM VP, Finance & CFO · ALT Chief Financial Officer · AYTU Chief Financial Officer · NEOS Chief Financial Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
ALT Altimmune, Inc. A Award2024-01-312024-02-014,621$2.69 $12.4K45,012SEC↗
ALT Altimmune, Inc. M Exercise deriv2024-01-302024-02-019,275— $027,825SEC↗
ALT Altimmune, Inc. M Exercise2024-01-302024-02-019,275— $042,566SEC↗
ALT Altimmune, Inc. F Tax w/h2024-01-302024-02-012,175$9.80 $21.3K40,391SEC↗
ALT Altimmune, Inc. A Award deriv2024-01-252024-01-29163,200— $0163,200SEC↗
ALT Altimmune, Inc. A Award deriv2024-01-252024-01-2958,400— $058,400SEC↗
ALT Altimmune, Inc. M Exercise deriv2023-12-292024-01-0212,500— $025,000SEC↗
ALT Altimmune, Inc. M Exercise2023-12-292024-01-0212,500— $036,335SEC↗
ALT Altimmune, Inc. F Tax w/h2023-12-292024-01-023,044$11.25 $34.2K33,291SEC↗
ALT Altimmune, Inc. A Award2023-07-312023-08-021,825$2.81 $5.1K23,835SEC↗
ALT Altimmune, Inc. P Buy2023-03-242023-03-2410,000$4.31 $43.1K22,010SEC↗
ALT Altimmune, Inc. A Award2023-01-312023-02-021,172$10.21 $12.0K12,010SEC↗
ALT Altimmune, Inc. A Award deriv2023-01-302023-02-01105,000— $0105,000SEC↗
ALT Altimmune, Inc. A Award deriv2023-01-302023-02-0137,100— $037,100SEC↗
ALT Altimmune, Inc. M Exercise deriv2022-12-312023-01-0312,500— $037,500SEC↗
ALT Altimmune, Inc. F Tax w/h2022-12-312023-01-033,028$16.45 $49.8K10,838SEC↗
ALT Altimmune, Inc. M Exercise2022-12-312023-01-0312,500— $013,866SEC↗
ALT Altimmune, Inc. A Award2022-07-312022-08-031,366$6.86 $9.4K1,366SEC↗
ALT Altimmune, Inc. A Award deriv2021-12-312022-01-0450,000— $050,000SEC↗
ALT Altimmune, Inc. A Award deriv2021-12-312022-01-04150,000— $0150,000SEC↗
AYTU AYTU BIOPHARMA, INC A Award2021-03-312021-04-0555,000— $068,734SEC↗
NEOS Neos Therapeutics, Inc. D To issuer deriv2021-03-192021-03-1912,500— $00SEC↗
NEOS Neos Therapeutics, Inc. D To issuer deriv2021-03-192021-03-1986,167— $00SEC↗
NEOS Neos Therapeutics, Inc. D To issuer deriv2021-03-192021-03-1960,230— $00SEC↗
NEOS Neos Therapeutics, Inc. D To issuer deriv2021-03-192021-03-1950,000— $00SEC↗
NEOS Neos Therapeutics, Inc. D To issuer deriv2021-03-192021-03-1945,000— $00SEC↗
NEOS Neos Therapeutics, Inc. D To issuer deriv2021-03-192021-03-1956,250— $00SEC↗
NEOS Neos Therapeutics, Inc. D To issuer deriv2021-03-192021-03-19230,276— $00SEC↗
NEOS Neos Therapeutics, Inc. D To issuer deriv2021-03-192021-03-19115,000— $00SEC↗
NEOS Neos Therapeutics, Inc. D To issuer2021-03-192021-03-19126,245— $00SEC↗
NEOS Neos Therapeutics, Inc. F Tax w/h2021-03-022021-03-1614,825$0.84 $12.5K126,245SEC↗
NEOS Neos Therapeutics, Inc. F Tax w/h2021-03-012021-03-161,390$0.88 $1.2K141,070SEC↗
NEOS Neos Therapeutics, Inc. A Award deriv2020-03-022020-03-04115,000— $0115,000SEC↗
NEOS Neos Therapeutics, Inc. A Award2020-03-022020-03-04100,000— $00SEC↗
NEOS Neos Therapeutics, Inc. A Award deriv2019-03-012019-03-04230,276— $0230,276SEC↗
NEOS Neos Therapeutics, Inc. P Buy2018-12-122018-12-135,000$2.16 $10.8K42,460SEC↗
NEOS Neos Therapeutics, Inc. A Award deriv2018-03-012018-03-0556,250— $056,250SEC↗
NEOS Neos Therapeutics, Inc. A Award2018-03-012018-03-0518,750— $037,460SEC↗
NEOS Neos Therapeutics, Inc. A Award deriv2017-05-012017-05-0245,000— $045,000SEC↗
NEOS Neos Therapeutics, Inc. A Award2017-05-012017-05-0215,000— $018,710SEC↗
NEOS Neos Therapeutics, Inc. P Buy2016-08-252016-08-253,710$6.82 $25.3K3,710SEC↗
NEOS Neos Therapeutics, Inc. A Award deriv2016-04-012016-04-0150,000— $050,000SEC↗
NEOS Neos Therapeutics, Inc. A Award deriv2015-09-012015-09-0360,230— $060,230SEC↗
TZYM TRANZYME INC A Award deriv2012-08-072012-08-0940,000— $040,000SEC↗